-
Morpholinodiazenyl chalcone blocks influenza A virus capsid uncoating by perturbing the clathrin-mediated vesicular trafficking pathway. Arch Pharm (Weinheim). 2024 Jun; 357(6):e2300670.
Thottasseri AA, Kaur G, Ramesh D, Banerjee I, Kannan T. PMID: 38487979.
View in:
PubMed Mentions: Fields:
Translation:
HumansAnimalsCells
-
Enhancing antifungal properties of chitosan by attaching isatin-piperazine-sulfonyl-acetamide pendant groups via novel imidamide linkage. Int J Biol Macromol. 2023 Jul 31; 244:125428.
Gowrivel Vijayakumar B, Ramesh D, Kumari S, Maity A, Pinnaka AK, Kannan T. PMID: 37330090.
View in:
PubMed Mentions:
1 Fields:
Translation:
HumansAnimals
-
Uracil derivatives as HIV-1 capsid protein inhibitors: design, in silico, in vitro and cytotoxicity studies. RSC Adv. 2022 Jun 07; 12(27):17466-17480.
Ramesh D, Mohanty AK, De A, Vijayakumar BG, Sethumadhavan A, Muthuvel SK, Mani M, Kannan T. PMID: 35765450; PMCID: PMC9190787.
View in:
PubMed Mentions:
-
Chitosan with pendant (E)-5-((4-acetylphenyl)diazenyl)-6-aminouracil groups as synergetic antimicrobial agents. J Mater Chem B. 2022 06 01; 10(21):4048-4058.
Vijayakumar BG, Ramesh D, Santhosh Manikandan K, Theresa M, Sethumadhavan A, Priyadarisini VB, Radhakrishnan EK, Mani M, Kannan T. PMID: 35507973.
View in:
PubMed Mentions:
2 Fields:
Translation:
AnimalsCells
-
Acetylene containing 2-(2-hydrazinyl)thiazole derivatives: design, synthesis, and in vitro and in silico evaluation of antimycobacterial activity against Mycobacterium tuberculosis. RSC Adv. 2022 Mar 15; 12(14):8771-8782.
Maganti LHB, Ramesh D, Vijayakumar BG, Khan MIK, Dhayalan A, Kamalraja J, Kannan T. PMID: 35424819; PMCID: PMC8984819.
View in:
PubMed Mentions:
1
-
Erratum: First-in-class pyrido[2,3-d]pyrimidine-2,4(1H,3H)-diones against leishmaniasis and tuberculosis: Rationale, in vitro, ex vivo studies and mechanistic insights. Arch Pharm (Weinheim). 2022 Apr; 355(4):e2270007.
Ramesh D, Sarkar D, Joji A, Singh M, Mohanty AK, Vijayakumar BG, Chatterjee M, Sriram D, Muthuvel SK, Kannan T. PMID: 35229349.
View in:
PubMed Mentions: Fields:
-
First-in-class pyrido[2,3-d]pyrimidine-2,4(1H,3H)-diones against leishmaniasis and tuberculosis: Rationale, in vitro, ex vivo studies and mechanistic insights. Arch Pharm (Weinheim). 2022 Apr; 355(4):e2100440.
Ramesh D, Sarkar D, Joji A, Singh M, Mohanty AK, G Vijayakumar B, Chatterjee M, Sriram D, Muthuvel SK, Kannan T. PMID: 35106845.
View in:
PubMed Mentions: Fields:
Translation:
Animals
-
Frontiers in Clinical Drug Research: Anti-Infectives. Therapeutic Targets for Emerging Zika Virus Infection and Vaccines in Clinical Trials. 2021; 8(8):260-299.
Deepthi Ramesh, Balaji Gowrivel Vijayakumar, Tharanikkarasu Kannan. View Publication.
-
Advances in Nucleoside and Nucleotide Analogues in Tackling Human Immunodeficiency Virus and Hepatitis Virus Infections. ChemMedChem. 2021 05 06; 16(9):1403-1419.
Ramesh D, Vijayakumar BG, Kannan T. PMID: 33427377.
View in:
PubMed Mentions:
8 Fields:
Translation:
HumansCellsPHPublic Health
-
Therapeutic potential of uracil and its derivatives in countering pathogenic and physiological disorders. Eur J Med Chem. 2020 Dec 01; 207:112801.
Ramesh D, Vijayakumar BG, Kannan T. PMID: 32927231.
View in:
PubMed Mentions:
10 Fields:
Translation:
HumansAnimals
-
In silico pharmacokinetic and molecular docking studies of natural flavonoids and synthetic indole chalcones against essential proteins of SARS-CoV-2. Eur J Pharmacol. 2020 Nov 05; 886:173448.
Vijayakumar BG, Ramesh D, Joji A, Jayachandra Prakasan J, Kannan T. PMID: 32768503; PMCID: PMC7406432.
View in:
PubMed Mentions:
51 Fields:
Translation:
Cells
-
Indole chalcones: Design, synthesis, in vitro and in silico evaluation against Mycobacterium tuberculosis. Eur J Med Chem. 2020 Jul 15; 198:112358.
Ramesh D, Joji A, Vijayakumar BG, Sethumadhavan A, Mani M, Kannan T. PMID: 32361610.
View in:
PubMed Mentions:
11 Fields:
Translation:
HumansAnimalsCells